8MV0.F BioHarvest Sciences Inc.

Consumer Defensive Packaged Foods Frankfurt Exchange
1.41 EUR
Close of Nov 12, 2026
1.10 6.30
Market cap
EUR 32.0M
P/E
-
P/B
1.90x
ROE
-64.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 8MV0.F undervalued?

Graham number

The Graham number of BioHarvest Sciences Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioHarvest Sciences Inc. fundamental analysis

No fundamental analysis for BioHarvest Sciences Inc. yet.

BioHarvest Sciences Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supple…

Full company profile